A Study to Evaluate the Pharmacokinetic, Pharmacodynamic Characteristics and the Safety After Administration by Doses of BR1400-1, BR1400-2, BR1400-3 in Healthy Adult Volunteers
Clinical trial NCT06889064 · COMPLETED
Trial details
- NCT number
- NCT06889064
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-24
- Primary completion
- 2024-10-08
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.